Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Net revenue	$ 904,015	$ 751,944
Cost of sales (exclusive of amortization shown separately below)	386,667	301,304
Amortization of acquired intangible assets	11,059	11,979
Total cost of sales	397,726	313,283
Gross profit	506,289	438,661
Operating expenses:
Selling, general and administrative	176,719	158,989
Research and development	59,950	54,533
Amortization of acquired intangible assets	7,707	8,243
Total operating expenses	244,376	221,765
Income from operations	261,913	216,896
Other income (loss), net:
Interest (expense) income, net	(5,360)	(6,725)
Loss attributable to equity method investments (note 5)	(1,386)	(2,288)
Gain (loss) on equity investments (note 5)	5,612	8,476
Other, net	(1,991)	(505)
Total other income (loss), net	(3,125)	(1,042)
Income before income taxes	258,788	215,854
Income taxes	55,175	37,482
Net income	$ 203,613	$ 178,372
Basic earnings per share (note 9)	$ 1.40	$ 1.23
Diluted earnings per share (note 9)	1.39	1.22
Dividend declared per share	$ 0.42	$ 0.39
Basic shares outstanding (000's)	145,680	144,900
Diluted shares outstanding (000's)	146,860	146,100
Sleep And Respiratory Care [Member]
Net revenue	$ 806,499	$ 659,801
Cost of sales (exclusive of amortization shown separately below)	349,681	268,990
Amortization of acquired intangible assets	900	1,955
Software As A Service [Member]
Net revenue	97,516	92,143
Cost of sales (exclusive of amortization shown separately below)	36,986	32,314
Amortization of acquired intangible assets	$ 10,159	$ 10,024